MedTech Dive February 14, 2024
Elise Reuter

The genetic testing company hopes to keep its employees on payroll as it works through a court-overseen sale.

Dive Brief:

  • Invitae filed for Chapter 11 protection late Tuesday, intended to keep the genetic testing firm running as it pays down debt.
  • The San Francisco-based company had about $535 million in assets and about $1.62 billion in debts as of Sept. 30, according to a filing with the U.S. Bankruptcy Court for the District of New Jersey.
  • Invitae is asking for approval to keep paying its approximately 1,235 employees as it goes through the bankruptcy process, according to a court filing.

Dive Insight:

Invitae had taken several steps to pare down expenses before filing for bankruptcy. The company sold...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Precision Medicine
Revolutionizing Primary Care: The Role of Pharmacogenomics and AI in Personalized Medicine
BioAro Announces Real Time DNA Decoding Technology
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future

Share This Article